Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Among 41 women who underwent RRSO, 2 BRCA1 carriers developed a PPC (4.9%).
|
28848147 |
2017 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To assess the clinical value of peritoneal washing cytology (PWC) in women with BRCA1 or BRCA2 mutations and women from a family with hereditary breast and/or ovarian cancer (HBOC) undergoing risk-reducing salpingo-oophorectomy (RRSO) in detecting primary peritoneal cancer (PPC) or occult ovarian/fallopian tube cancer.
|
26768420 |
2016 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.
|
26439132 |
2016 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
From 2004 to 2009, women undergoing surgical staging for nonmucinous epithelial ovarian carcinoma, including fallopian tube and primary peritoneal carcinoma, were invited to participate in tumor banking and genetic counseling for BRCA1 and BRCA2 mutations.
|
22776961 |
2012 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This study immunohistochemically evaluated (by Ki-67 and p53 staining) the presence of p53 signature, TILT lesions, and STIC in 14 consecutive cases of prophylactic salpingo-oophorectomy in women with BRCA-1/2 mutation (bilateral salpingo-oophorectomy), 11 cases of macroscopically inconspicuous adnexae of patients with primary contralateral tubal cancer (TC), 9 cases of primary peritoneal cancer (PPC), and 10 cases of serous ovarian borderline tumors, evaluating the fallopian tubes (using the Sectioning and Extensively Examining the FIMbria protocol), ovarian surface epithelium, and ovarian cortical inclusion cysts.
|
21804388 |
2011 |
Primary peritoneal carcinoma
|
0.500 |
SusceptibilityMutation
|
disease |
ORPHANET |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Seventy-nine patients with EOC/PPC and germline BRCA1/2 mutations were identified.
|
20406939 |
2010 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Women with mutations in BRCA1 or BRCA2 are at tremendously increased lifetime risk of both breast and BRCA-associated gynecologic (ovarian, fallopian tube, and primary peritoneal) cancer.
|
17617523 |
2007 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To estimate the incidence of ovarian, fallopian tube, and primary peritoneal cancer in women who carry a deleterious mutation in BRCA1 or BRCA2.
|
16835424 |
2006 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We hypothesized that older age and having a BRCA1 mutation would be predictors for tubal or ovarian neoplasia and that a careful surgical and pathologic protocol would lead to a low rate of subsequent primary peritoneal cancer.
|
16731090 |
2006 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The similar frequency distribution of BRCA1/2 mutations in PPC and OvC observed in the present study indicates that these mutations may predispose to PPC as well and that this neoplasm is part of the hereditary breast-ovarian cancer syndrome.
|
12504628 |
2003 |
Primary peritoneal carcinoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Other cancers of interest that appeared in the BRCA1-linked families included primary peritoneal cancer, cancer of the fallopian tube, and malignant melanoma.
|
7759076 |
1995 |
Primary peritoneal carcinoma
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|